Thirty Madison Company Overview: Business Model, Brands, and Clinical Evidence

What Thirty Madison Actually Does

Thirty Madison operates as a holding company for three condition-focused telehealth brands, each built around a narrow clinical scope and a subscription pharmacy model. Patients complete an online questionnaire, a licensed physician reviews it asynchronously, and approved prescriptions ship from an in-house pharmacy.

The company raised over $140 million in venture funding by 2022 and positioned itself against broader telehealth platforms like Hims & Hers and Ro by going deep rather than wide. Each sub-brand targets a single chronic condition. Keeps handles androgenetic alopecia. Cove focuses on migraine. Picnic covers seasonal and perennial allergies. This vertical approach means the intake forms, follow-up cadences, and formularies are tailored to each condition rather than adapted from a general template.

The model works best for patients who already have a working diagnosis and need ongoing prescription access without repeated office visits. It is less suited for diagnostic uncertainty, complex comorbidities, or conditions requiring physical examination. The American Medical Association has raised concerns about asynchronous-only care models when used for conditions that benefit from longitudinal physician relationships [1].

Keeps: The Hair Loss Brand Under the Microscope

Keeps is the most visible of Thirty Madison's brands and prescribes two FDA-approved medications for androgenetic alopecia: oral finasteride (1 mg daily) and topical minoxidil (5% solution or foam). Both have decades of clinical data.

The landmark finasteride trial published in the Journal of the American Academy of Dermatology followed 1,553 men over two years and found that 1 mg daily finasteride increased hair count by a mean of 107 hairs per 1-inch target area compared to a decrease of 58 hairs with placebo [2]. A five-year extension study confirmed sustained efficacy, with 48% of men showing increased hair growth and 42% showing no further loss at year five [3].

Minoxidil's evidence base is equally established. A 48-week randomized trial (N=393) demonstrated that 5% topical minoxidil produced 45% more hair regrowth than the 2% formulation at week 48 [4], data that led to the FDA's approval of the over-the-counter 5% strength. Keeps sells both prescription finasteride and OTC minoxidil through its platform.

Pricing for Keeps starts at roughly $10 per month for generic finasteride and ranges to $35 or more for combination plans. These prices are competitive with GoodRx cash-pay pricing for the same generics at retail pharmacies. The convenience premium is the bundled consultation, not typically the drug cost itself.

One limitation worth noting: Keeps does not prescribe dutasteride, oral minoxidil, or spironolactone for female pattern hair loss. Patients with more advanced Norwood stage V+ alopecia or those seeking combination therapy beyond finasteride plus topical minoxidil may find the formulary restrictive compared to a dermatologist or a broader telehealth platform.

Cove: Migraine Management and the Evidence Behind It

Cove prescribes acute and preventive migraine medications through the same asynchronous model. The acute formulary includes sumatriptan, rizatriptan, and naratriptan. Preventive options span propranolol, topiramate, amitriptyline, and the newer CGRP-targeting agents like rimegepant (Nurtec ODT).

Triptans remain the first-line acute treatment per the American Headache Society's 2019 consensus statement, which noted that "triptans, including sumatriptan, are the most well-established acute treatments for migraine and should be offered early in treatment" [5]. Sumatriptan's key trial showed a 2-hour pain-free rate of 34% for sumatriptan 100 mg versus 11% for placebo across pooled analyses [6].

For prevention, the addition of CGRP antagonists to Cove's formulary reflects newer evidence. The Phase 3 trial of rimegepant for migraine prevention (N=747) demonstrated a reduction of 4.3 migraine days per month with rimegepant 75 mg every other day versus 3.5 days with placebo (P<0.001) [7]. Dr. Richard Lipton, director of the Montefiore Headache Center, stated in reviewing this data: "Having a single molecule that works for both acute treatment and prevention is a meaningful advance for patients who want to simplify their regimen" [7].

Cove's pricing for generic triptans sits around $10 to $18 per month. Brand-name CGRP drugs like rimegepant run significantly higher, often $75 or more per month through the platform, though manufacturer copay cards can offset this. Patients with insurance may find it cheaper to get CGRP prescriptions through their in-network provider.

Picnic: The Allergy Vertical

Picnic rounds out Thirty Madison's portfolio with prescription allergy treatment. The formulary includes nasal corticosteroids (fluticasone, mometasone), oral antihistamines (cetirizine, levocetirizine), and sublingual immunotherapy referrals in select cases.

The evidence for intranasal corticosteroids in allergic rhinitis is strong. A Cochrane review of 40 trials (N=not individually pooled) confirmed that intranasal corticosteroids are superior to oral antihistamines for overall nasal symptom control, with moderate-certainty evidence favoring fluticasone and mometasone specifically [8].

Picnic's value proposition is less clear-cut than Keeps or Cove. Many of the medications it prescribes are available over the counter. The American Academy of Allergy, Asthma & Immunology guidelines recommend stepping up to prescription-strength options only when OTC treatments fail [9]. A patient who responds well to store-bought cetirizine and fluticasone nasal spray has limited reason to pay for a subscription consultation.

Where Picnic adds value is in the convenience of a curated regimen. Some patients cycle through multiple OTC products without a coherent strategy. A physician-guided selection of the right antihistamine, nasal spray, and timing protocol can reduce trial-and-error. The monthly cost ranges from $15 to $45 depending on the medication bundle.

Is Thirty Madison Legit? Evaluating the Care Model

The legitimacy question comes up frequently in consumer searches, and the answer requires separating medication legitimacy from care model adequacy. The medications themselves are FDA-approved generics dispensed from licensed pharmacies. That part is straightforward.

The care model is where nuance enters. Asynchronous consultations (questionnaire-based, no live interaction) work adequately for conditions with clear diagnostic criteria and well-established first-line treatments. Androgenetic alopecia in a 28-year-old male with gradual vertex thinning is a textbook use case. So is episodic migraine in a patient with a confirmed diagnosis.

The model shows strain with diagnostic ambiguity. A patient attributing hair loss to male pattern baldness might actually have telogen effluvium, alopecia areata, or thyroid-driven shedding. The American Academy of Dermatology's guidelines on alopecia emphasize that "a thorough history and physical examination, including the pull test and scalp examination, are essential for accurate classification" [10]. An asynchronous photo review cannot replicate a pull test.

The National Academy of Medicine's 2024 report on telehealth quality noted that "asynchronous modalities may be appropriate for straightforward clinical scenarios but should include clear escalation pathways for complex presentations" [11]. Thirty Madison does include physician follow-up messaging in its platforms, and patients can request a synchronous consultation in some cases, but the default pathway remains asynchronous.

Thirty Madison vs. Alternatives: How the Brands Compare

The D2C telehealth market has become crowded. Hims & Hers, Ro, and Lemonaid Health all compete for the same patient population. The differences matter.

Hims & Hers operates a broader formulary across more conditions, including GLP-1 prescribing, mental health, and dermatology. This breadth means patients can consolidate multiple prescriptions under one platform. Thirty Madison's narrower focus means deeper condition-specific intake forms but fewer options if your needs extend beyond hair, migraine, or allergies.

Ro (formerly Roman) has invested more heavily in at-home diagnostics, including lab work integration for testosterone and metabolic panels. Thirty Madison does not offer diagnostic lab work through its platform, which limits its ability to monitor treatment safety. Finasteride, for example, can affect PSA levels, and the FDA labeling notes that clinicians should establish a baseline PSA before initiating therapy [12].

On pricing, the differences are marginal for most generic medications. Finasteride through Keeps, Hims, or Ro falls within a $10 to $20 per month range. The real differentiator is the consultation experience, follow-up responsiveness, and whether the platform catches cases that should be escalated to in-person care.

Dr. Shari Lipner, a dermatologist at Weill Cornell Medicine, noted in a JAMA Dermatology commentary: "Teledermatology platforms vary widely in diagnostic accuracy, and patients should understand that a subscription medication service is not a substitute for a comprehensive dermatologic evaluation" [13].

What Thirty Madison Prescribes: Full Formulary Breakdown

Across its three brands, Thirty Madison's combined formulary spans roughly 15 to 20 unique medications. Here is what each brand currently offers:

Keeps: finasteride 1 mg oral, minoxidil 5% topical (solution and foam), ketoconazole 2% shampoo, biotin supplements. The prescription medications (finasteride) require physician authorization. Minoxidil and ketoconazole are available OTC but sold through the platform at bundled pricing.

Cove: sumatriptan (25, 50 to 100 mg), rizatriptan (5 to 10 mg), naratriptan (2.5 mg), ubrogepant (Ubrelvy), rimegepant (Nurtec ODT), propranolol, topiramate, amitriptyline, magnesium supplements. The gepant-class medications represent the newest additions and carry significantly higher costs.

Picnic: fluticasone propionate nasal spray, mometasone furoate nasal spray, azelastine nasal spray, cetirizine, levocetirizine, montelukast (with appropriate safety counseling per FDA boxed warning [14]).

The formulary is intentionally conservative. You will not find controlled substances, compounded medications, or off-label prescriptions. This limits clinical flexibility but reduces regulatory and safety risk for a high-volume asynchronous model.

Pricing and the Subscription Model

Thirty Madison's revenue depends on recurring subscriptions. Each brand charges a consultation fee (often waived on the first visit) plus a monthly or quarterly medication charge. There are no insurance billing options for consultations. Medications are cash-pay.

Representative monthly costs as of 2026:

• Keeps finasteride: $10 to $17 per month (quarterly plans reduce per-unit cost)
• Keeps combination plan (finasteride + minoxidil): $28 to $40 per month
• Cove generic triptan: $10 to $18 per month
• Cove rimegepant (Nurtec): $75+ per month (manufacturer savings card may apply)
• Picnic basic plan: $15 to $20 per month
• Picnic premium plan: $35 to $45 per month

For patients with prescription drug insurance, filling the same generics at a retail pharmacy through their plan may be cheaper. The platform's value is clearest for uninsured patients or those who want to avoid scheduling an office visit. A Health Affairs analysis of D2C telehealth pricing found that cash-pay telehealth prescription costs were within 15% of retail generic pricing for most common medications, with the convenience of bundled consultation accounting for the difference [15].

Safety Monitoring and Follow-Up Gaps

No telehealth platform review is complete without addressing safety monitoring. Finasteride carries known risks including sexual side effects (reported in 1.3% to 3.8% of men in clinical trials) and a post-marketing signal for depression that prompted an FDA label update in 2012 [16]. Triptans are contraindicated in patients with uncontrolled hypertension, coronary artery disease, or hemiplegic migraine per AHS guidelines [5].

Thirty Madison's intake questionnaires screen for these contraindications. The limitation is that screening depends entirely on patient self-report. There are no vital signs, no lab values, and no physical exam findings to corroborate. For most healthy adults seeking first-line generics, this is a reasonable trade-off. For patients with cardiovascular risk factors, medication interactions, or atypical symptom presentations, an in-person evaluation provides a layer of safety that asynchronous questionnaires cannot replicate.

The platform does allow patients to message their assigned physician with concerns, and follow-up check-ins occur at standard intervals (typically 90 days for ongoing prescriptions). Cancellation is available at any time without penalty, which reduces the financial risk of trying the service.

Patients taking finasteride through Keeps should discuss PSA screening with their primary care physician independently, as Endocrine Society guidelines recommend baseline and interval PSA monitoring for men on 5-alpha reductase inhibitors [17].